Armenia vs Syria: HIV-positive TB patients on ART (antiretroviral therapy)
Armenia
100.0%
in 2024
Syria
100.0%
in 2021
Armenia rank
1st
Syria rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Armenia
- Syria
How they compare
Armenia currently reports 100.0% against 100.0% in Syria, a difference of 0.0%.
Across all 9 years both countries report, Syria has been ahead every year.
Armenia ranks 1st and Syria ranks 1st of 144 countries.
Syria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Armenia | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.0% | 100.0% | 50.0% | Syria |
| 2010s | 87.6% | 100.0% | 12.4% | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Armenia or Syria?
- Armenia, at 100.0% against 100.0% in Syria as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Armenia and Syria?
- 0.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Syria?
- 9 years are reported by both, from 2007 to 2019.
- How do Armenia and Syria rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Armenia ranks 1st and Syria ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.